Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methylenetetrahydrofolate dehydrogenase (MTHFD) refers to a family of enzymes involved in folate-mediated one-carbon metabolism. These enzymes catalyze the reversible oxidation of 5,10-methylenetetrahydrofolate to 5,10-methenyltetrahydrofolate using NADP+ as an electron acceptor. This activity is central to the interconversion of one-carbon units required for nucleotide biosynthesis and methylation reactions. MTHFD enzymes are key players in the folate cycle: Provide one-carbon units for synthesis of purines, thymidylates (dTMP), and remethylation of homocysteine to methionine. Support DNA synthesis/repair by generating substrates for thymidylate synthase. Participate in glyoxylate/dicarboxylate metabolism and overall cellular redox balance through NADPH production. MTHFD isoforms are being explored as potential drug targets—especially MTHFD2 due to its role in cancer cell proliferation and immune evasion mechanisms.
Inhibition of enzymatic activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methylenetetrahydrofolate Dehydrogenase (None).